tyb
my guess is 'word of mouth'
>AstraZeneca shares drop 6% after company announces ‘routine’ safety pause in coronavirus vaccine trial
Sauce from CNBC and Forbes
AstraZeneca shares drop 6% after company announces ‘routine’ safety pause in coronavirus vaccine trial
PUBLISHED TUE, SEP 8 20205:47 PM EDTUPDATED 4 HOURS AGO
Berkeley Lovelace Jr.
@BERKELEYJR
KEY POINTS
AstraZeneca shares fell more than 6% in after-hours trading Tuesday after the company said its late-stage trial for a potential coronavirus vaccine had been put on hold due to safety concerns.
“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials,” the company said in a statement to CNBC.
AstraZeneca began its trial late last month and is one of three companies currently in late-stage testing for a potential vaccine. The other two are Pfizer and Moderna, which both began their trials in late July.
https://www.cnbc.com/2020/09/08/astrazeneca-shares-fall-after-coronavirus-vaccine-study-is-put-on-hold.html
AstraZeneca Puts Phase 3 Vaccine Trial On Hold, Shares Drop 6%
Daniel Cassady
Daniel CassadyForbes Staff, Business
https://www.forbes.com/sites/danielcassady/2020/09/08/astrazeneca-puts-phase-3-vaccine-trial-on-hold-shares-drop-6/